Somatostatin, Olfaction, and Neurodegeneration

Somatostatin, Olfaction, and Neurodegeneration

Alzheimer’s and Parkinson’s diseases are the most prevalent neurodegenerative disorders in aging. Hyposmia has been described as an early symptom that can precede cognitive and motor deficits by decades. Certain regions within the olfactory system, such as the anterior olfactory nucleus, display the...

Full description

Bibliographic Details
Main Authors:	Daniel Saiz-Sanchez, Isabel Ubeda-Bañon, Alicia Flores-Cuadrado, Melania Gonzalez-Rodriguez, Sandra Villar-Conde, Veronica Astillero-Lopez, Alino Martinez-Marcos
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-02-01
Series:	Frontiers in Neuroscience
Subjects:	α-synuclein amyloid-β anterior olfactory nucleus hyposmia tau
Online Access:	https://www.frontiersin.org/article/10.3389/fnins.2020.00096/full

Similar Items

The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
by: Isabel Ubeda-Bañon, et al.
Published: (2020-06-01)

Neurodegeneration and Astrogliosis in the Human CA1 Hippocampal Subfield Are Related to hsp90ab1 and bag3 in Alzheimer’s Disease
by: Melania Gonzalez-Rodriguez, et al.
Published: (2021-12-01)

Olfaction and Colour Vision: What Can They Tell Us about Parkinson’s Disease?
by: Irene Dall’Antonia, et al.
Published: (2018-11-01)

Somatostatin and Astroglial Involvement in the Human Limbic System in Alzheimer’s Disease
by: Melania Gonzalez-Rodriguez, et al.
Published: (2021-08-01)

Neuronal and glial characterization in the rostrocaudal axis of the human anterior olfactory nucleus: Involvement in Parkinson’s disease
by: Sandra Villar-Conde, et al.
Published: (2022-07-01)

Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease
by: Blake Highet, et al.
Published: (2020-08-01)

Possible effects of low testosterone levels on olfactory function in males
by: Tolga Kırgezen, et al.
Published: (2021-11-01)

Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease
by: Ryszard Pluta, et al.
Published: (2021-02-01)

The Effect of Corticosteroids on Post-Covid-19 Smell Loss: A Meta-Analysis
by: Mona Kabiri, et al.
Published: (2023-09-01)

Brain clearance of protein aggregates: a close-up on astrocytes
by: Veronica Giusti, et al.
Published: (2024-01-01)

Assessment and Scientific Progresses in the Analysis of Olfactory Evoked Potentials
by: Pasquale Arpaia, et al.
Published: (2022-06-01)

Smell disorders associated with COVID-19 infection
by: Mohammad Waheed El-Anwar, et al.
Published: (2021-05-01)

Hyposmia in COVID-19: Temporal Recovery of Smell: A Preliminary Study
by: Barbara Verro, et al.
Published: (2023-08-01)

Olfactory Dysfunction in Patients with Coronavirus Disease 2019: A Narrative Review
by: Mehdi Askari
Published: (2023-04-01)

Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms
by: Lavandan Jegatheeswaran, et al.
Published: (2023-08-01)

Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis
by: Katti Blessi Sara, et al.
Published: (2022-01-01)

Cytological organization of the alpha component of the anterior olfactory nucleus and olfactory limbus
by: Jorge A Larriva-Sahd
Published: (2012-06-01)

Transmissibility versus Pathogenicity of Self-Propagating Protein Aggregates
by: Byron Caughey, et al.
Published: (2019-11-01)

Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration
by: Andrey Y. Abramov, et al.
Published: (2020-06-01)

Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
by: Wen Li, et al.
Published: (2024-03-01)

Role of Aromatic Herbs and Spices in Salty Perception of Patients with Hyposmia
by: Antonella Rosa, et al.
Published: (2022-11-01)

Olfactory Evaluation in Clinical Medical Practice
by: Květoslav Červený, et al.
Published: (2022-11-01)

Comparison between four published definitions of hyposmia in Parkinson's disease
by: Sofia Kanavou, et al.
Published: (2021-08-01)

Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial
by: Charlotte Hautefort, et al.
Published: (2023-11-01)

Evolution of COVID-19-related olfactory disorders: A systematic review and meta-analysis
by: Foster T Orji, et al.
Published: (2022-01-01)

Impact of Subthalamic Deep Brain Stimulation on Hyposmia in Patients With Parkinson's Disease Is Influenced by Constipation and Dysbiosis of Microbiota
by: Chao Li, et al.
Published: (2021-04-01)

Anosmia, trigeminal nerve dysfunction, and COVID-19: A personal account
by: Hideaki Moteki
Published: (2021-12-01)

α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise
by: Simona Daniele, et al.
Published: (2018-01-01)

Protein Biomarkers for the Diagnosis of Alzheimer’s Disease at Different Stages of Neurodegeneration
by: Mar Pérez, et al.
Published: (2020-09-01)

The Female Impact in the World of Neurodegeneration
by: Celeste Gonzalez Osorio, et al.
Published: (2021-10-01)

Looking Beyond the Core: The Role of Flanking Regions in the Aggregation of Amyloidogenic Peptides and Proteins
by: Sabine M. Ulamec, et al.
Published: (2020-12-01)

Functional imaging of cortical feedback projections to the olfactory bulb
by: Markus eRothermel, et al.
Published: (2014-07-01)

Characterization of odor-evoked neural activity in the olfactory peduncle
by: Graham A. Cousens
Published: (2020-12-01)

Behavioral Phenotype in the TgF344-AD Rat Model of Alzheimer’s Disease
by: Rachel Michelle Saré, et al.
Published: (2020-06-01)

Effect of Ultra-Micronized Palmitoylethanolamide and Luteolin on Olfaction and Memory in Patients with Long COVID: Results of a Longitudinal Study
by: Pietro De Luca, et al.
Published: (2022-08-01)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
by: Simona Daniele, et al.
Published: (2018-02-01)

Validation and cross‐cultural adaptation of the Arabic version of the self‐reported mini olfactory questionnaire (Self‐MOQ)
by: Rayan Alfallaj, et al.
Published: (2023-12-01)

Olfactory Dysfunction following COVID-19 and the Potential Benefits of Olfactory Training
by: Abdullah A. Alarfaj, et al.
Published: (2023-07-01)

Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease
by: Hu S, et al.
Published: (2020-03-01)

Protein phosphorylation in neurodegeneration: friend or foe?
by: Sandra eTenreiro, et al.
Published: (2014-05-01)